大麻使用不影响减重手术患者体重下降结局
该回顾性研究纳入364例袖状胃切除术患者,比较每周至少使用一次大麻者(CU)与非使用者(non-CU)的减重结局。CU组31例(8.5%),non-CU组333例(91.5%)。两组在术后1周至2年的多余体重减少率(EWL)无差异;CU组在3年(52.9% vs 38.1%,p=0.094)和5年(49.8% vs 32.7%,p=0.068)呈更高EWL趋势。术后恶心呕吐(PONV)发生率及严重程度无显著差异。
要点
- 大麻使用者减重术后体重下降不劣于非使用者。
- CU组3年、5年EWL呈更高趋势但未达统计学显著。
- 两组PONV发生率与严重程度无显著差异。
核心结论
- 大麻使用者接受减重手术后体重下降结局不劣于非使用者,挑战了食欲刺激导致减重效果不佳的常见假设。
研究设计与样本
- 回顾性综述,纳入364例袖状胃切除术患者,分为大麻使用者(CU,每周至少一次,31例,8.5%)与非使用者(non-CU,333例,91.5%)。
主要发现
- CU与non-CU在术后1周、1月、3月、6月、9月、1年、2年的EWL无差异。
- CU组3年EWL为52.9% vs non-CU 38.1%(p=0.094),5年为49.8% vs 32.7%(p=0.068),呈更高趋势但未达显著。
- 两组术后1年及以上PONV发生率或严重程度无显著差异。
临床怎么用
- 对于每周至少使用一次大麻的减重手术患者,不应仅因担心体重下降不佳而限制手术。
局限性
- 回顾性设计,样本量较小(CU组仅31例),需更大规模、长期、多中心研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The legalization of cannabis in several states has led to increased documented use in the population. Bariatric surgery patients are no exception with estimates of anywhere from 6 to 8%. Cannabis is known to be associated with increased appetite, mood disorders, hyperphagia, and rarely, hyperemesis, which can potentially affect post-surgical weight loss. We aim to study the differences in bariatric surgery outcomes between cannabis users and non-users. METHODS: A retrospective review identified patients undergoing bariatric surgery. Patients were divided into two groups, cannabis users (CU) and non-cannabis users (non-CU). Cannabis users (defined as using at least once weekly) and a group of non-users were called to obtain additional information. Primary outcome was weight loss. Secondary outcomes included incidence of post-operative nausea and vomiting (PONV), length of stay (LOS), readmission, and need for additional intervention. RESULTS: A cohort of 364 sleeve gastrectomy patients met inclusion criteria, 31 (8.5%) CU and 333 (91.5%) non-CU. There was no difference in EWL between CU and non-CU at 1 week, 1 month, 3 months, 6 months, 9 months, 1 year, and 2 years. However, the CU group trended towards greater EWL at 3 years (52.9% vs. 38.1%, p = 0.094) and at 5 years (49.8% vs. 32.7%, p = 0.068). There were no significant differences between CU and non-CU with respect to either incidence or severity of PONV at one year after surgery or longer follow-up. CONCLUSION: Cannabis users did not experience inferior weight loss after bariatric surgery despite common assumptions that appetite stimulation can lead to suboptimal weight loss outcomes. Our findings add to other work challenging this dogma. Larger, long-term, multicenter studies are warranted.
引用
- Huang EY, Broderick RC, Li JZ, et al. Weight loss outcomes are not compromised in bariatric patients using cannabis. Surg Endosc. 2022. PMID: 35861881. doi:10.1007/s00464-022-09453-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。